Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$781M |
| 2 |
Amazon
AMZN
|
+$728M |
| 3 |
AABA
Altaba Inc
AABA
|
+$535M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$296M |
| 5 |
Booking.com
BKNG
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$353M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$261M |
| 3 |
Alibaba
BABA
|
+$228M |
| 4 |
Citigroup
C
|
+$170M |
| 5 |
DuPont de Nemours
DD
|
+$165M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.47% |
| 2 | Technology | 2.03% |
| 3 | Consumer Discretionary | 1.46% |
| 4 | Financials | 1.01% |
| 5 | Healthcare | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
First Financial Bankshares
FFIN
$4.79B
| $3.14M | ﹤0.01% |
142,226
+82,086
| +136% | +$1.65M |
|
3052
HEICO Corp Class A
HEI.A
$34.9B
| $3.14M | ﹤0.01% |
98,939
+19,903
| +25% | +$620K |
|
3053
CALL
Wintrust Financial
WTFC
$10.3B
| $3.14M | ﹤0.01% |
41,100
-27,100
| -40% | -$1.94M |
|
3054
PUT
The GEO Group
GEO
$4.25B
| $3.14M | ﹤0.01% |
106,200
-49,500
| -32% | -$1.56M |
|
3055
Match Group
MTCH
$9.54B
| $3.14M | ﹤0.01% |
180,620
-163,857
| -48% | -$3.01M |
|
3056
PUT
Itron
ITRI
$4.27B
| $3.14M | ﹤0.01% |
46,300
-8,500
| -16% | -$558K |
|
|
WCG
3057
DELISTED
Wellcare Health Plans, Inc.
WCG
| $3.13M | ﹤0.01% |
+17,457
| New | +$2.89M |
|
|
GNC
3058
DELISTED
GNC Holdings, Inc.
GNC
| $3.13M | ﹤0.01% |
371,764
-300,851
| -45% | -$2.26M |
|
3059
ProShares Ultra Financials
UYG
$846M
| $3.13M | ﹤0.01% |
90,432
-16,221
| -15% | -$530K |
|
3060
CALL
Evolent Health
EVH
$520M
| $3.13M | ﹤0.01% |
123,500
-28,900
| -19% | -$695K |
|
|
DMC
3061
Del Monte Corp
DMC
$1.5B
| $3.13M | ﹤0.01% |
61,412
+22,878
| +59% | +$1.24M |
|
|
FM
3062
DELISTED
iShares Frontier and Select EM ETF
FM
| $3.13M | ﹤0.01% |
109,411
-21,587
| -16% | -$624K |
|
3063
PUT
Teradyne
TER
$55.5B
| $3.12M | ﹤0.01% |
103,800
+71,600
| +222% | +$2.41M |
|
3064
CALL
Universal Health Services
UHS
$10.1B
| $3.11M | ﹤0.01% |
25,500
+11,900
| +88% | +$1.42M |
|
3065
Sunoco
SUN
$14.1B
| $3.11M | ﹤0.01% |
101,600
-329,031
| -76% | -$9.81M |
|
3066
CALL
Nektar Therapeutics
NKTR
$2.48B
| $3.1M | ﹤0.01% |
10,587
-1,533
| -13% | -$443K |
|
|
GBT
3067
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.1M | ﹤0.01% |
113,500
-210,700
| -65% | -$6.27M |
|
3068
PUT
National Fuel Gas
NFG
$7.89B
| $3.1M | ﹤0.01% |
55,500
+50,000
| +909% | +$2.81M |
|
3069
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
$332M
| $3.1M | ﹤0.01% |
+117,999
| New | +$3.16M |
|
3070
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$432M
| $3.1M | ﹤0.01% |
33,857
-292
| -0.9% | -$26K |
|
|
ZEUS
3071
PUT
DELISTED
Olympic Steel
ZEUS
| $3.1M | ﹤0.01% |
159,000
+101,900
| +178% | +$1.87M |
|
3072
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.19B
| $3.1M | ﹤0.01% |
62,808
+9,303
| +17% | +$457K |
|
|
AAN.A
3073
CALL
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $3.09M | ﹤0.01% |
79,400
+31,000
| +64% | +$1.21M |
|
3074
PUT
Invesco Dorsey Wright Technology Momentum ETF
PTF
$566M
| $3.09M | ﹤0.01% |
+201,900
| New | +$3.09M |
|
|
CA
3075
PUT
DELISTED
CA, Inc.
CA
| $3.08M | ﹤0.01% |
89,500
+56,700
| +173% | +$1.83M |
|
Similar funds
Jeff Yass's Q2 2017 Portfolio in Review
As of Q2 2017, Jeff Yass held 10,525 positions worth $228B, up 15% from $198B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Jeff Yass's Q2 2017 filing shows 1,702 new, 3,804 increased, 3,457 reduced and 1,419 closed positions. Its largest new stake was Altaba Inc: 9,835,232 shares worth $536M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $353M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2017 buy was Altaba Inc: 9,835,232 shares worth $536M.
- Jeff Yass added most to Apple in Q2 2017, an estimated $781M increase.
- Jeff Yass's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $353M.
- Jeff Yass fully exited Alphabet (Google) Class C in Q2 2017, selling an estimated $261M.
- Jeff Yass's ten largest holdings make up 22% of its $228B portfolio in Q2 2017.
- Jeff Yass opened 1,702 new positions and closed 1,419 in Q2 2017.
- Jeff Yass's portfolio value rose 15% quarter-over-quarter to $228B.
Based on Susquehanna International Group's 13F filing for Q2 2017, filed 15 Aug 2017.